HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gordon, M. S. Articles by Burt, M. E. Search for Related Content PubMed PubMed Citation Articles by Gordon, M. S. Articles by Burt, M. E.

The Journal of Thoracic and Cardiovascular Surgery, Vol 101, 843-854, Copyright © 1991 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association

ARTICLES

Soft tissue sarcomas of the chest wall. Results of surgical resection

MS Gordon, SI Hajdu, MS Bains and ME Burt
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, N.Y. 10021.

Primary soft tissue sarcomas of the chest wall are uncommon, and data concerning treatment and results are sparse. Most studies have categorized these tumors as truncal sarcomas and inferred a poor prognosis. To assess the results of surgical treatment, we reviewed our 40-year experience. Methods: Records of 189 patients admitted to our institution from 1948 to 1988 were reviewed. Pathologic material was available for review in the 149 cases (79%) that comprise this report. Survival was calculated by the Kaplan-Meier method, with comparisons by log-rank analysis and significance defined as p less than 0.05. Results: Ages ranged from 3 weeks to 86 years (median, 38 years); the ratio of male to female patients was 2:1. The initial complaint was mass or pain in 97% of the cases. Ninety sarcomas (60%) were high grade and 59 (40%) were low grade. Histologic types were as follows: desmoid tumor (n = 32, 21%); liposarcoma (n = 23, 15%); rhabdomyosarcoma (n = 18, 12%); fibrosarcoma (n = 17, 11%); embryonal rhabdomyosarcoma (n = 14, 9%); malignant peripheral nerve tumor (n = 13, 9%); malignant fibrous histiocytoma (n = 11, 7%); spindle cell sarcoma (n = 4, 3%); tenosynovial sarcoma (n = 3, 3%); hemangiopericytoma (n = 3, 3%); alveolar soft part sarcoma (n = 3, 3%); and other types (n = 12, 9%). Resection was the primary treatment in 140 cases (94%). Local recurrence developed in 27%. Metastases occurred in 52 (35%) of the cases (metachronous in 42, synchronous in 10) and were more common in patients with high-grade disease (46/90, 51%) than in those with low- grade disease (6/59, 10%). Overall 5-year survival was 66%. Five-year survival rate for those with high-grade sarcomas (49%) was significantly lower than that for low-grade sarcomas (90%, p less than 0.0001). Tumor size and age of patient were not prognostic. Conclusions: Survival of patients with primary soft tissue sarcomas of the chest wall after resection is similar to that of patients with sarcomas of the extremities. Resection alone provides acceptable survival (90% at 5 years) for those with low-grade sarcomas, but adjuvant treatment should be considered for those with high-grade sarcomas.

This article has been cited by other articles:

				M. W. Wouters, A. N. van Geel, L. Nieuwenhuis, H. van Tinteren, C. Verhoef, F. van Coevorden, and H. M. Klomp Outcome After Surgical Resections of Recurrent Chest Wall Sarcomas J. Clin. Oncol., November 1, 2008; 26(31): 5113 - 5118. [Abstract] [Full Text] [PDF]

				C. Zisis, A. Dountsis, A. Nikolaides, and J. Dahabreh Desmoid Tumors of the Chest Wall Asian Cardiovasc Thorac Ann, October 1, 2006; 14(5): 359 - 362. [Abstract] [Full Text] [PDF]

				Y. Altemur Karamustafaoglu and A. Gungor Giant soft tissue liposarcoma of chest wall J. Thorac. Cardiovasc. Surg., May 1, 2005; 129(5): 1189 - 1190. [Full Text] [PDF]

				J. L. Gross, R. N. Younes, F. J. Haddad, D. Deheinzelin, C. A. L. Pinto, and M. L. V. Costa Soft-Tissue Sarcomas of the Chest Wall: Prognostic Factors Chest, March 1, 2005; 127(3): 902 - 908. [Abstract] [Full Text] [PDF]

				S. Fischer, M. de Perrot, Y. Sekine, and S. Keshavjee Long-term survival after multiple resections of a fibrosarcoma involving the lung and chest wall Eur. J. Cardiothorac. Surg., August 1, 2001; 20(2): 421 - 423. [Abstract] [Full Text] [PDF]

				K. Athanassiadi, G. Kalavrouziotis, D. Rondogianni, A. Loutsidis, A. Hatzimichalis, and I. Bellenis Primary chest wall tumors: early and long-term results of surgical treatment Eur. J. Cardiothorac. Surg., May 1, 2001; 19(5): 589 - 593. [Abstract] [Full Text] [PDF]

				A. Iyoda, K. Hiroshima, M. Baba, T. Fujisawa, T. Yusa, and H. Ohwada Expression of vascular endothelial growth factor in thoracic sarcomas Ann. Thorac. Surg., May 1, 2001; 71(5): 1635 - 1639. [Abstract] [Full Text] [PDF]

				M. S. Allen, D. L. Miller, C. Deschamps, V. F. Trastek, and P. C. Pairolero Chest wall tumors Ann. Thorac. Surg., March 1, 1999; 67(3): 889 - 890. [Full Text] [PDF]

				M. Burt, J. K. Ihde, S. I. Hajdu, J. W. Smith, M. S. Bains, R. Downey, N. Martini, V. W. Rusch, and R. J. Ginsberg Primary Sarcomas Of The Mediastinum: Results Of Therapy J. Thorac. Cardiovasc. Surg., March 1, 1998; 115(3): 671 - 680. [Abstract] [Full Text]

				M. Incarbone, M. Nava, C. Lequaglie, G. Ravasi, and U. Pastorino STERNAL RESECTION FOR PRIMARY OR SECONDARY TUMORS J. Thorac. Cardiovasc. Surg., July 1, 1997; 114(1): 93 - 99. [Abstract] [Full Text]